openPR Logo
Press release

Deadline on March 22nd coming up in Lawsuit for Investors in Fate Therapeutics, Inc. (NASDAQ: FATE)

02-27-2023 10:23 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Shareholders Foundation

A Deadline is coming up on March 22, 2023 in the lawsuit for certain investors in Fate Therapeutics, Inc. (NASDAQ: FATE).

A Deadline is coming up on March 22, 2023 in the lawsuit for certain investors in Fate Therapeutics, Inc. (NASDAQ: FATE).

A deadline is coming up on March 22, 2023 in the lawsuit filed for certain investors of Fate Therapeutics, Inc. (NASDAQ: FATE) over alleged securities laws violations by Fate Therapeutics, Inc.

Investors who purchased shares of Fate Therapeutics, Inc. (NASDAQ: FATE) have certain options and there are strict and short deadlines running. Deadline: March 22, 2023. NASDAQ: FATE stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

According to the complaint filed in the U.S. District Court for the Southern District of California the plaintiff alleges on behalf of purchasers of Fate Therapeutics, Inc. (NASDAQ: FATE) common shares between April 2, 2020 and January 5, 2023, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that between April 2, 2020 and January 5, 2023, the Defendants made false and/or misleading statements and/or failed to disclose that the Janssen Collaboration Agreement was less sustainable than Fate had represented to investors, that accordingly, certain the clinical programs, milestone payments, and royalty payments associated with the Janssen Collaboration Agreement could not be relied upon as future revenue sources, that as a result, Fate had overstated the impact of the Janssen Collaboration Agreement's on Fate's long-term clinical and commercial profitability, and that as a result, the Company's public statements were materially false and misleading at all relevant times.

Those who purchased shares of Fate Therapeutics, Inc. (NASDAQ: FATE) have certain options and should contact the Shareholders Foundation.

Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Deadline on March 22nd coming up in Lawsuit for Investors in Fate Therapeutics, Inc. (NASDAQ: FATE) here

News-ID: 2951266 • Views:

More Releases from Shareholders Foundation

Lawsuit filed for Investors in Charge Enterprises, Inc. (formerly NASDAQ: CRGE) in effort to recover losses
Lawsuit filed for Investors in Charge Enterprises, Inc. (formerly NASDAQ: CRGE) …
An investor, who purchased shares of Charge Enterprises, Inc. (formerly NASDAQ: CRGE), filed a lawsuit over alleged violations of Federal Securities Laws by the former CEO and CFO of Charge Enterprises, Inc in connection with certain allegedly false and misleading statements made between December 15, 2021 and February 28, 2024. Investors who purchased shares of Charge Enterprises, Inc. (formerly NASDAQ: CRGE) between December 15, 2021 and February 28, 2024, and continue
Deadline on June 10th coming up in Lawsuit for Investors in shares of Ocugen, Inc. (NASDAQ: OCGN)
Deadline on June 10th coming up in Lawsuit for Investors in shares of Ocugen, In …
A deadline is coming up on June 10, 2024 in the lawsuit filed for certain investors of Ocugen, Inc. (NASDAQ: OCGN) over alleged securities laws violations by Ocugen, Inc. Investors who purchased shares of Ocugen, Inc. (NASDAQ: OCGN ) have certain options and there are strict and short deadlines running. Deadline: June 10, 2024. NASDAQ: OCGN stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. According to
Investigation announced for Investors in FMC Corporation (NYSE: FMC) over potential Wrongdoing
Investigation announced for Investors in FMC Corporation (NYSE: FMC) over potent …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of FMC Corporation. Investors who are current long term investors in FMC Corporation (NYSE: FMC) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term investors in NYSE: FMC stocks follows a lawsuit filed against FMC Corporation over
Investigation announced for Long-Term Investors who lost money with Advance Auto Parts, Inc. (NYSE: AAP)
Investigation announced for Long-Term Investors who lost money with Advance Auto …
An investigation was announced for long-term investors in shares of Advance Auto Parts, Inc. (NYSE: AAP) concerning potential breaches of fiduciary duties by certain directors of Advance Auto Parts, Inc. Investors who are current long term investors in Advance Auto Parts, Inc. (NYSE: AAP) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long

All 5 Releases


More Releases for Fate

Aircraft Engines Market - The Eventual Fate of Aircraft Engines Transmissions Is …
Aircraft Engines Market 2020-2030: An aircraft engine is the part of the propulsion system for an aircraft used to generate mechanical power. In an aircraft engine, air is drawn in at the front through an inlet, compressed by a fan, mixed with fuel and combusted, and then fired out as a hot, fast moving exhaust at the back, which propels the airplane forward. Download Report Sample (210 Pages PDF with Insights)
"The Turn of Fate" by Martin Hicks is published
ISBN #978-1789553543 The Turn of Fate by Martin Hicks is published The maritime saga of US Confederate raider Palmetto continues About the Book: It is the autumn of 1864 and the Confederate raider Palmetto is in Far Eastern waters, where an encounter with Malay pirates and an attack by hostile islanders have left her seriously undermanned. Thomas Grover, Palmetto’s captain, must continue to elude the US warships hunting for his ship, while somehow finding a
Accept your fate: You can't escape the Construction Material Testing Equipments …
Construction Material Testing Equipments Market Overview: Planet Market Reports adds “Construction Material Testing Equipments Market 2018 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2025” Report in Database. This report provides in depth study of “Construction Material Testing Equipments Market” using SWOT analysis Strength, Weakness, Opportunities and Threat to the organization. The Construction Material Testing Equipments Market report also provides an in-depth survey of key players in the market which
Accept your fate: You can't escape the Zoxamide
There are a wide range of fungicides. Zoxamide, with a relatively lower performance price ratio, is not used in many fields. In China, there are only two enterprises authorized to produce zoxamide, Dalian Chemphy Chemical Co., Ltd. and Dongguan Ruidefeng Biotechnology Co., Ltd. In the future, along with development of manufacturing technology and reduction of prices, zoxamide may have a well prospect. Save Upto 15% on this Report @ https://www.researchbeam.com/research-on-zoxamide-in-china-2017-2022-market/purchase-enquiry Table of Content Methodology
Accept your fate: You can't escape the Global Irrigation Controllers Market 2017
Qyresearchreports include new market research report "Global Irrigation Controllers Market Professional Survey Report 2017" to its huge collection of research reports. The global market for Irrigation Controllers is analyzed in a detailed market research report added to the extensive research report database of QYResearchReports.com. The report analyses the current state of the Irrigation Controllers market and forecasts the growth prospects of various elements of the market over the period of 2017-2022.
Launch of the iNvictus Masters of Fate Fellowship Program
FOR IMMEDIATE RELEASE Contact: Edward R. Boyd,Jr. Chief Strategy Officer 919-251-8255 eboyd@invictusoffice.com INvictus Office Center Hosts the Launch of the iNvictus Masters of Fate Fellowship Program to Erase Inequities, Boost Minority Entrepreneurial, Business and Non-profit Ventures iNvictus non-profit arm, iNvictus Forward Outreach, publically unveils eight entrepreneurs selected for inaugural Masters of Fate Fellowship Forbes magazine reports 8 of 10 entrepreneurs who start a business fail within the first two years. Among the culprits: Leadership breakdowns; lack